Skip to Content
Merck

Clinical Inquiry: which treatments help women with reduced libido?

The Journal of family practice (2013-02-14)
Keia Hobbs, Lara Handler
PMID23405381
ABSTRACT

Several treatments produce modest, but statistically significant, clinical increases in sexual desire and function in women. The testosterone transdermal patch improves hypoactive sexual desire disorder (HSDD) in postmenopausal women.

MATERIALS
Product Number
Brand
Product Description
B102
Sigma-Aldrich
Bupropion hydrochloride, ≥98% (HPLC), solid
B-034
Supelco
Bupropion hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®